FDA approves trial for wearable artificial kidney

February 10 2014

ATLANTA — The U.S. Food & Drug Administration has approved the start of the first human clinical trials in the United States for the wearable artificial kidney designed by Beverly Hills, Calif.-based Blood Purification Technologies Inc. The announcement was made by Victor Gura, MD, during the opening session on Sunday of the Annual Dialysis Conference taking place in Atlanta.

The device was one of three products related to end-stage renal disease that were awarded a special fast-track to market status in April 2012. The program, called Innovation Pathway, is a new system designed to help medical devices reach patients in a safe, timely, and collaborative manner. An implantable Renal Assist Device (iRAD) being developed by the University of California, San Francisco, and a Hemoaccess Valve System (HVS) designed by Greenville, S.C.-based CreatiVasc Medical were also awarded FDA fast track status

Original article: http://www.nephrologynews.com/articles/110030-fda-approves-trial-for-wearable-artificial-kidney

Recent News

An invitation to an online patient update from the clinical team at St George’s Hospital Renal Unit.
July 29 2020
Former St George’s Transplant Surgeon - Mr Adil El Tayar has died of Covid-19
March 30 2020
Update from St George’s Hospital renal team on Coronavirus (COVID-19) - 23rd June 2020
March 24 2020
St George’s Patient - Villy Nielsen - reaches 50 year anniversary of his kidney transplant
October 2 2019
St George’s Hospital Charity - New dialysis Unit Campaign
September 22 2019

Join Us

Register with us, become a member and subscribe to our newsletters including the latest on the impact of coronavirus for patients at St George’s Hospital.